CR20140380A - UBIQUITINE ACTIVATING ENZYME PIRAZOLOPIRIMIDINYL INHIBITORS - Google Patents
UBIQUITINE ACTIVATING ENZYME PIRAZOLOPIRIMIDINYL INHIBITORSInfo
- Publication number
- CR20140380A CR20140380A CR20140380A CR20140380A CR20140380A CR 20140380 A CR20140380 A CR 20140380A CR 20140380 A CR20140380 A CR 20140380A CR 20140380 A CR20140380 A CR 20140380A CR 20140380 A CR20140380 A CR 20140380A
- Authority
- CR
- Costa Rica
- Prior art keywords
- pirazolopirimidinyl
- ubiquitine
- inhibitors
- activating enzyme
- formula
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Se describen entidades químicas que inhiben la enzima activadora de ubiquitina (UAE), cada una de las cuales es un compuesto de Fórmula (I) o una sal farmaceúticamente aceptable de este, donde Y es Fórmula (II).Chemical entities that inhibit the ubiquitin activating enzyme (UAE) are described, each of which is a compound of Formula (I) or a pharmaceutically acceptable salt thereof, where Y is Formula (II).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261600070P | 2012-02-17 | 2012-02-17 | |
| PCT/US2013/026113 WO2013123169A1 (en) | 2012-02-17 | 2013-02-14 | Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR20140380A true CR20140380A (en) | 2014-10-28 |
Family
ID=48982730
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR20140380A CR20140380A (en) | 2012-02-17 | 2014-08-12 | UBIQUITINE ACTIVATING ENZYME PIRAZOLOPIRIMIDINYL INHIBITORS |
Country Status (30)
| Country | Link |
|---|---|
| US (4) | US9290500B2 (en) |
| EP (3) | EP2814791A4 (en) |
| JP (1) | JP6122877B2 (en) |
| KR (1) | KR20140123104A (en) |
| CN (1) | CN104136399B (en) |
| AR (1) | AR092797A1 (en) |
| BR (1) | BR112014020365B1 (en) |
| CA (1) | CA2864672C (en) |
| CL (1) | CL2014002181A1 (en) |
| CO (1) | CO7071135A2 (en) |
| CR (1) | CR20140380A (en) |
| DO (1) | DOP2014000187A (en) |
| EA (1) | EA035020B1 (en) |
| EC (1) | ECSP14019113A (en) |
| ES (1) | ES2739150T3 (en) |
| GE (1) | GEP201706687B (en) |
| HK (1) | HK1201817A1 (en) |
| IL (1) | IL234016A0 (en) |
| MA (1) | MA35932B1 (en) |
| MX (1) | MX352963B (en) |
| NZ (1) | NZ628969A (en) |
| PE (1) | PE20142244A1 (en) |
| PH (1) | PH12014501832A1 (en) |
| SG (2) | SG10201606581RA (en) |
| TN (1) | TN2014000351A1 (en) |
| TW (1) | TWI593688B (en) |
| UA (1) | UA116534C2 (en) |
| UY (1) | UY34629A (en) |
| WO (1) | WO2013123169A1 (en) |
| ZA (1) | ZA201406103B (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8008307B2 (en) | 2006-08-08 | 2011-08-30 | Millennium Pharmaceuticals, Inc. | Heteroaryl compounds useful as inhibitors of E1 activating enzymes |
| BR112014020365B1 (en) | 2012-02-17 | 2023-02-23 | Takeda Pharmaceutical Company Limited | UBIQUITIN ACTIVATING ENZYME PIRAZOLOPYRIMIDINY INHIBITORS |
| CN104684559A (en) | 2012-08-03 | 2015-06-03 | 米伦纽姆医药公司 | Indole-substituted pyrrolopyrimidinyl inhibitors of Uba6 |
| US9695154B2 (en) | 2013-07-02 | 2017-07-04 | Millennium Pharmaceuticals, Inc. | Heteroaryl inhibitors of sumo activating enzyme |
| UY36198A (en) | 2014-07-01 | 2016-01-29 | Millennium Pharm Inc | USEFUL HETEROARILO COMPOUNDS AS SUMO ACTIVATOR ENZYME INHIBITORS |
| WO2016069392A1 (en) | 2014-10-29 | 2016-05-06 | Millennium Pharmaceuticals, Inc. | Administration of ubiquitin-activating enzyme inhibitor and chemotherapeutic agents |
| WO2016069393A1 (en) | 2014-10-29 | 2016-05-06 | Millennium Pharmaceuticals, Inc. | Administration of ubiquitin-activating enzyme inhibitor and radiation |
| MX2021004769A (en) | 2018-10-30 | 2021-08-24 | Kronos Bio Inc | Compounds, compositions, and methods for modulating cdk9 activity. |
| WO2023021498A1 (en) * | 2021-08-16 | 2023-02-23 | Moya Bio Ltd. | Fused azole and furan based nucleoside analogs and uses thereof |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003073989A2 (en) | 2002-02-28 | 2003-09-12 | Biota, Inc. | Nucleoside 5'-monophosphate mimics and their prodrugs |
| DE60313872T2 (en) | 2002-09-04 | 2008-01-17 | Schering Corp. | PYRAZOLOE1,5-ATPYRIMIDINES AS INHIBITORS CYCLINE-DEPENDENT KINASES |
| ES2285164T3 (en) | 2002-09-04 | 2007-11-16 | Schering Corporation | PIRAZOLOPIRIMIDINAS AS INHIBITORS OF CYCLINE-DEPENDENT KINASES. |
| US7563798B2 (en) | 2002-09-04 | 2009-07-21 | Schering Corporation | Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors |
| US7196092B2 (en) | 2002-09-04 | 2007-03-27 | Schering Corporation | N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| EP1608652A1 (en) | 2003-03-31 | 2005-12-28 | Vernalis (Cambridge) Limited | Pyrazolopyrimidine compounds and their use in medicine |
| JP2005008581A (en) * | 2003-06-20 | 2005-01-13 | Kissei Pharmaceut Co Ltd | NEW PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME AND APPLICATION THEREOF |
| WO2005037845A1 (en) | 2003-10-17 | 2005-04-28 | Rigel Pharmaceuticals, Inc. | Benzothiazole and thiazole[5,5-b] pyridine compositions and their use as ubiquitin ligase inhibitors |
| EP1758873A1 (en) | 2004-06-22 | 2007-03-07 | Rigel Pharmaceuticals, Inc. | Ubiquitin ligase inhibitors |
| JP5048520B2 (en) | 2005-02-04 | 2012-10-17 | ミレニアム ファーマシューティカルズ， インコーポレイテッド | Inhibitor of E1 activating enzyme |
| WO2007044426A2 (en) | 2005-10-06 | 2007-04-19 | Schering Corporation | Pyrazolopyrimidines as protein kinase inhibitors |
| EP2402334B1 (en) | 2006-02-02 | 2016-06-29 | Millennium Pharmaceuticals, Inc. | Inhibitors of E1 Activating Enzymes |
| EP1992008A1 (en) * | 2006-02-28 | 2008-11-19 | Sez Ag | Device and method for liquid treating disc-like articles |
| MY157177A (en) | 2006-08-08 | 2016-05-13 | Millennium Pharm Inc | Heteroaryl compounds useful as inhibitors of e1 activating enzymes |
| US8008307B2 (en) | 2006-08-08 | 2011-08-30 | Millennium Pharmaceuticals, Inc. | Heteroaryl compounds useful as inhibitors of E1 activating enzymes |
| CN107021895A (en) | 2007-06-12 | 2017-08-08 | 尔察祯有限公司 | Antiseptic |
| ES2758027T3 (en) * | 2007-08-02 | 2020-05-04 | Millennium Pharm Inc | Intermediates for the synthesis of E1 activity activating enzyme inhibitors |
| US9216983B2 (en) | 2007-12-21 | 2015-12-22 | Board Of Regents, University Of Texas System | Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity |
| WO2010086040A1 (en) | 2009-01-29 | 2010-08-05 | Biomarin Iga, Ltd. | Pyrazolo-pyrimidines for treatment of duchenne muscular dystrophy |
| WO2010088518A2 (en) | 2009-01-31 | 2010-08-05 | Kalypsys, Inc. | Heterocyclic modulators of gpr119 for treatment of disease |
| WO2010132110A1 (en) | 2009-05-14 | 2010-11-18 | Millennium Pharmaceuticals, Inc. | Hydrochloride salt of ((1s,2s,4r)-4-{4-[(1s)-2,3-dihydro-1h-inden-1-ylamino]-7h-pyrrolo [2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl)methyl sulfamate |
| JP5879273B2 (en) | 2010-03-01 | 2016-03-08 | ジーティーエックス・インコーポレイテッド | Compounds for treating cancer |
| US20120077814A1 (en) | 2010-09-10 | 2012-03-29 | Zhong Wang | Sulfonamide, sulfamate, and sulfamothioate derivatives |
| BR112014004239A2 (en) | 2011-08-24 | 2017-03-21 | Millennium Pharm Inc | nedd8 activating enzyme inhibitors |
| BR112014020365B1 (en) | 2012-02-17 | 2023-02-23 | Takeda Pharmaceutical Company Limited | UBIQUITIN ACTIVATING ENZYME PIRAZOLOPYRIMIDINY INHIBITORS |
| CN104684559A (en) | 2012-08-03 | 2015-06-03 | 米伦纽姆医药公司 | Indole-substituted pyrrolopyrimidinyl inhibitors of Uba6 |
| US9695154B2 (en) | 2013-07-02 | 2017-07-04 | Millennium Pharmaceuticals, Inc. | Heteroaryl inhibitors of sumo activating enzyme |
| UY36198A (en) | 2014-07-01 | 2016-01-29 | Millennium Pharm Inc | USEFUL HETEROARILO COMPOUNDS AS SUMO ACTIVATOR ENZYME INHIBITORS |
-
2013
- 2013-02-14 BR BR112014020365-2A patent/BR112014020365B1/en active IP Right Grant
- 2013-02-14 CN CN201380009784.8A patent/CN104136399B/en active Active
- 2013-02-14 SG SG10201606581RA patent/SG10201606581RA/en unknown
- 2013-02-14 SG SG11201404757WA patent/SG11201404757WA/en unknown
- 2013-02-14 JP JP2014557765A patent/JP6122877B2/en active Active
- 2013-02-14 EA EA201400831A patent/EA035020B1/en not_active IP Right Cessation
- 2013-02-14 WO PCT/US2013/026113 patent/WO2013123169A1/en active Application Filing
- 2013-02-14 EP EP13748707.0A patent/EP2814791A4/en not_active Withdrawn
- 2013-02-14 EP EP16205139.5A patent/EP3173413B1/en active Active
- 2013-02-14 UA UAA201409297A patent/UA116534C2/en unknown
- 2013-02-14 KR KR1020147025556A patent/KR20140123104A/en not_active Application Discontinuation
- 2013-02-14 MX MX2014009944A patent/MX352963B/en active IP Right Grant
- 2013-02-14 NZ NZ628969A patent/NZ628969A/en not_active IP Right Cessation
- 2013-02-14 ES ES16205139T patent/ES2739150T3/en active Active
- 2013-02-14 CA CA2864672A patent/CA2864672C/en active Active
- 2013-02-14 GE GEAP201313560A patent/GEP201706687B/en unknown
- 2013-02-14 EP EP19170607.6A patent/EP3536692B1/en active Active
- 2013-02-14 US US13/767,314 patent/US9290500B2/en active Active
- 2013-02-14 PE PE2014001278A patent/PE20142244A1/en active IP Right Grant
- 2013-02-15 UY UY0001034629A patent/UY34629A/en not_active Application Discontinuation
- 2013-02-15 AR ARP130100480A patent/AR092797A1/en unknown
- 2013-02-18 TW TW102105676A patent/TWI593688B/en not_active IP Right Cessation
-
2014
- 2014-08-07 IL IL234016A patent/IL234016A0/en unknown
- 2014-08-11 TN TNP2014000351A patent/TN2014000351A1/en unknown
- 2014-08-12 CR CR20140380A patent/CR20140380A/en unknown
- 2014-08-13 PH PH12014501832A patent/PH12014501832A1/en unknown
- 2014-08-14 CL CL2014002181A patent/CL2014002181A1/en unknown
- 2014-08-15 DO DO2014000187A patent/DOP2014000187A/en unknown
- 2014-08-20 ZA ZA2014/06103A patent/ZA201406103B/en unknown
- 2014-09-10 MA MA37338A patent/MA35932B1/en unknown
- 2014-09-16 CO CO14205517A patent/CO7071135A2/en unknown
- 2014-09-17 EC ECIEPI201419113A patent/ECSP14019113A/en unknown
-
2015
- 2015-03-05 HK HK15102227.4A patent/HK1201817A1/en unknown
-
2016
- 2016-02-19 US US15/048,007 patent/US9663525B2/en active Active
-
2017
- 2017-04-17 US US15/488,800 patent/US9796725B2/en active Active
- 2017-09-08 US US15/699,818 patent/US10202389B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR20140380A (en) | UBIQUITINE ACTIVATING ENZYME PIRAZOLOPIRIMIDINYL INHIBITORS | |
| AR110381A2 (en) | BIUTYL INHIBITORS OF TIROSINA CINASA DE BRUTON | |
| EA201590224A1 (en) | IMIDAZOTRIASINCARBONITRILE USED AS KINASE INHIBITORS | |
| UY34177A (en) | NEW INHIBITING COMPOUNDS OF PHOSPHODESTERASE TYPE 10A | |
| UA110338C2 (en) | Chemical compounds | |
| BR112013016595A2 (en) | neprilysin inhibitors | |
| EA201490596A1 (en) | NEW DYHYDROCHINOLIN-2-IT DERIVATIVES | |
| CR20140229A (en) | NEW BICYCLIC DERIVATIVES OF DIHIDROISOQUINOLIN-1-ONA | |
| EA201490567A1 (en) | NEW BICYCLIC DERIVATIVES OF DIHYDROCHINOLIN-2-IT | |
| RS54730B1 (en) | Inhibitors of beta-secretase | |
| UA111382C2 (en) | Protein kinase inhibitors | |
| CR20140106A (en) | COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF THE QUINASE C-KIT | |
| RS54207B1 (en) | Condensed imidazolylimidazoles as antiviral compounds | |
| EA201290880A1 (en) | NEW CONNECTIONS - ENZYME INHIBITORS | |
| EA201490724A1 (en) | SUBSTITUTED COMPOUNDS OF TETRAHYDROISOCHINOLINE AS INHIBITORS OF XIA | |
| UY34445A (en) | NEW INHIBITING COMPOUNDS OF TYPE 10A PHOSPHODIESTERASE | |
| UY34092A (en) | NEW COMPOUNDS AS JAK INHIBITORS | |
| UY34851A (en) | MACROCYCLIC INHIBITORS OF VIRUS FLAVIVIRIDAE | |
| UY33958A (en) | GLUCOSILCERAMIDE SINTASA INHIBITORS | |
| UY33937A (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING DPP-4 AND / OR SGLT-2 AND METFORMIN INHIBITORS | |
| EA201792021A1 (en) | JAK INHIBITOR | |
| CR20130539A (en) | TRIAZOLOPIRIDINS | |
| UY34216A (en) | New compounds that inhibit the activity of Lp-PLA2 | |
| EA201492210A1 (en) | COMPOUNDS INHIBITING CATECHOL-O-METHYLTRANSFERASE ACTIVITY | |
| EA201591634A1 (en) | DIHYDROPYRIDOPYRIMIDINE COMPOUNDS |